§ Federal grant opportunity · RFA-DA-28-013
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed). The deadline is February 8, 2027 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- February 8, 2027
- Award range
- Award amount not published
- Eligibility
- nonprofits non higher education with 501c3, city or township governments, public and indian housing authorities, small businesses, public and state institutions of higher education, special district governments, private institutions of higher education, state governments, county governments, other, independent school districts, federally recognized native american tribal governments, nonprofits non higher education without 501c3, for profit organizations other than small businesses, other native american tribal organizations
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-DA-28-013
Program overview
The National Institute on Drug Abuse (NIDA) invites applications to renew and expand the Collaboratory on Neural Ensembles and Used Substances (NExUS). NExUS is a collaborative research program to decode how substance use experiences and addictive neurobehavioral states are represented in the brain at the level of cell populations. This funding opportunity seeks applications that propose systematic and scalable methods to identify, map, and analyze groups of neurons that respond to used substances. The goal is to create a comprehensive, multimodal database and use it to test hypotheses about how specific neural population activity patterns relate to behavioral states associated with substance use and substance use disorders (SUD), including intoxication, craving, and dependence.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before February 8, 2027, allowing time for registration and validation.
Related grant opportunities
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
- Mid-scale Research Infrastructure-1
- GROWING CONVERGENCE RESEARCH
- Grid Supply Chain Alternatives to Lead Energy Dominance (SCALED)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.